Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Possible consequences and potential for improvement for time of diagnosis for intracranial germ cell tumours

Dr Juliet Hale - Newcastle University, UK
Possible consequences and potential for improvement for time of diagnosis for intracranial germ cell tumours ( Dr Juliet Hale - Newcastle University, UK )
29 May 2013

Time to diagnosis for intracranial germ cell tumours: Possible consequences and potential for improvement

Dr Juliet Hale - Newcastle University, UK
Time to diagnosis for intracranial germ cell tumours: Possible consequences and potential for improvement ( Dr Juliet Hale - Newcastle University, UK )
29 May 2013

Blood biopsies for tumour cell detection

Dr Alberto Bardelli - University of Torino Medical School, Turin, Italy
Blood biopsies for tumour cell detection ( Dr Alberto Bardelli - University of Torino Medical School, Turin, Italy )
29 May 2013

Advances and perspectives on biomarkers

Dr Nicola Normanno - Institute Fondazione Pascale, Naples, Italy
Advances and perspectives on biomarkers ( Dr Nicola Normanno - Institute Fondazione Pascale, Naples, Italy )
16 May 2013

Integrating breast cancer genomics and proteomics

Dr Gordon Mills - University of Texas MD Anderson Cancer Center, Houston, USA
Integrating breast cancer genomics and proteomics ( Dr Gordon Mills - University of Texas MD Anderson Cancer Center, Houston, USA )
15 May 2013

Genetic and clinical factors best for predicting late recurrence in oestrogen receptor positive breast cancer

Dr Ivana Sestak - Queen Mary University of London, UK
Genetic and clinical factors best for predicting late recurrence in oestrogen receptor positive breast cancer ( Dr Ivana Sestak - Queen Mary University of London, UK )
15 May 2013

Breast cancer heterogeneity no barrier to predictive testing

Dr Michał Jarząb - Maria Skłodowska-Curie Institute of Oncology, Gliwice, Poland
Breast cancer heterogeneity no barrier to predictive testing ( Dr Michał Jarząb - Maria Skłodowska-Curie Institute of Oncology, Gliwice, Poland )
15 May 2013

Single cell sequencing techniques in early and late breast cancer

Dr Nicholas Navin - MD Anderson Cancer Center, Houston, TX, USA
Single cell sequencing techniques in early and late breast cancer ( Dr Nicholas Navin - MD Anderson Cancer Center, Houston, TX, USA )
15 May 2013

Multitarget FISH testing in lung cancer

Dr Lucas Bubendorf – Institute for Pathology, University Hospital, Basel, Switzerland
Multitarget FISH testing in lung cancer ( Dr Lucas Bubendorf – Institute for Pathology, University Hospital, Basel, Switzerland )
15 May 2013

Next generation sequencing in oncology

Dr Antonio Marchetti – University-Foundation, Chieti, Italy
Next generation sequencing in oncology ( Dr Antonio Marchetti – University-Foundation, Chieti, Italy )
15 May 2013

Opportunities and complications of PET CT

Dr Barbara Fischer – Rigshospitalet, Copenhagen, Denmark
Opportunities and complications of PET CT ( Dr Barbara Fischer – Rigshospitalet, Copenhagen, Denmark )
15 May 2013

Early effect of PI3K-Akt-mTOR blockade on in vitro 18F-FDG uptake in HER2 breast cancer resistant to trastuzumab

Dr Yanina Dockx - University of Antwerp, Edegem, Belgium
Early effect of PI3K-Akt-mTOR blockade on in vitro 18F-FDG uptake in HER2  breast cancer resistant to trastuzumab ( Dr Yanina Dockx - University of Antwerp, Edegem, Belgium )
15 May 2013